mgl-3196 and Cadaver

mgl-3196 has been researched along with Cadaver* in 1 studies

Other Studies

1 other study(ies) available for mgl-3196 and Cadaver

ArticleYear
Cell-Specific Transport and Thyroid Hormone Receptor Isoform Selectivity Account for Hepatocyte-Targeted Thyromimetic Action of MGL-3196.
    International journal of molecular sciences, 2022, Nov-08, Volume: 23, Issue:22

    Thyroid hormones (THs) and TH receptor-beta (TRβ) reduce hepatic triglycerides, indicating a therapeutic potential for TH analogs in liver steatosis. To avoid adverse extrahepatic, especially TRα-mediated effects such as tachycardia and bone loss, TH analogs with combined TRβ and hepatocyte specificity are desired. MGL-3196 is a new TH analog that supposedly meets these criteria. Here, we characterize the thyromimetic potential of MGL-3196 in cell-based assays and address its cellular uptake requirements. We studied the contribution of liver-specific organic anion transporters (OATP)1B1 and 1B3 to MGL-3196 action. The TR isoform-specific efficacy of MGL-3196 compared with 3,5,3'-triiodothyronine (T

    Topics: Animals; Cadaver; HEK293 Cells; Hepatocytes; Humans; Mice; Mice, Knockout; Protein Isoforms; Receptors, Thyroid Hormone; Thyroid Hormone Receptors beta; Triiodothyronine

2022